izpis_h1_title_alt

Fragment-sized thiazoles in fragment-based drug discovery campaigns : friend or foe?
ID Proj, Matic (Author), ID Hrast, Martina (Author), ID Knez, Damijan (Author), ID Bozovičar, Krištof (Author), ID Grabrijan, Katarina (Author), ID Meden, Anže (Author), ID Gobec, Stanislav (Author), ID Frlan, Rok (Author)

.pdfPDF - Presentation file, Download (2,30 MB)
MD5: E86DBB9F5C097394033A065F612F3404
URLURL - Source URL, Visit https://pubs.acs.org/doi/10.1021/acsmedchemlett.2c00429 This link opens in a new window

Abstract
Thiazoles exhibit a wide range of biological activities and therefore represent useful and attractive building blocks. To evaluate their usefulness and pinpoint their liabilities in fragment screening campaigns, we assembled a focused library of 49 fragment-sized thiazoles and thiadiazoles with various substituents, namely amines, bromides, carboxylic acids, and nitriles. The library was profiled in a cascade of biochemical inhibition assays, redox activity, thiol reactivity, and stability assays. Our study indicates that when thiazole derivatives are identified as screening hits, their reactivity should be carefully addressed and correlated with specific on-target engagement. Importantly, nonspecific inhibition should be excluded using experimental approaches and in silico predictions. To help with validation of hits identified in fragment screening campaigns, we can apply our high-throughput profiling workflow to focus on the most tractable compounds with a clear mechanism of action.

Language:English
Keywords:thiazoles, hit profiling, promiscuous compounds, frequent hitters, privileged scaffolds, fragments
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:Str. 1905–1910
Numbering:Vol. 13, iss. 12
PID:20.500.12556/RUL-143239 This link opens in a new window
UDC:547.78:615.4:54
ISSN on article:1948-5875
DOI:10.1021/acsmedchemlett.2c00429 This link opens in a new window
COBISS.SI-ID:130706947 This link opens in a new window
Publication date in RUL:09.12.2022
Views:694
Downloads:136
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:ACS medicinal chemistry letters
Publisher:American Chemical Society
ISSN:1948-5875
COBISS.SI-ID:2959217 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:hit profiliranje, promiskuitetne spojine, pogosti napadalci, privilegirani odri, fragmenti, tiazoli, farmacevtska kemija

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARRS - Slovenian Research Agency
Project number:J1-2484
Name:Razvoj protibakterijskih učinkovin z delovanjem na validirane tarče v biosintezi peptidoglikana

Funder:ARRS - Slovenian Research Agency
Funding programme:Young researchers

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back